Jeffrey Boone, M.D.
Founder and Director of the Boone Heart Institute
Estimated Time of Talk
This webinar will cover clinical implications and therapeutic approaches to patients who are poor responders to aspirin therapy.
- Learn how aspirin therapy reduces cardiovascular events.
- Review how 11-dhTXB2 levels can indicate aspirin effectiveness.
- Therapeutic considerations and additional testing for those who are poor responders to aspirin therapy.
Conflicts of Interest
Speaker- Amgen, Aralez, Cleveland HeartLab